Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.67 |
| ▸ | RAB9A | P51151 | 6/20 | 0.67 |
| ▸ | NPC1 | O15118 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | GAA | P10253 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | APP | P05067 | 6/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | SNCA | P37840 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30211717 | 1.00 | MAPT (0.67) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL29478087 | 0.88 | MAPT (0.67) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL3302516 | 0.88 | MAPT (0.67) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL2136152 | 0.84 | EGFR (0.60) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL25329016 | 0.83 | MAPT (0.69) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL30211740 | 0.83 | MAPT (0.69) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL7187329 | 0.83 | MAPT (0.72) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL4278803 | 0.82 | NPC1 (0.67) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL31530841 | 0.82 | MAPT (0.67) | MAPTKDM4ERAB9ANPC1MEN1 | |
| SCHEMBL13806278 | 0.82 | NPC1 (0.67) | MAPTKDM4ERAB9ANPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2023-07-27 | — | — | US | disclosed |
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2023-07-27 | — | — | US | disclosed |
| EP-4164891-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2023-04-19 | — | — | EP | disclosed |
| CN-115768631-A | Fluorescent composition comprising at least one benzoxazole compound for protecting products | 犯罪科学技术公司 | 2023-03-07 | — | — | CN | disclosed |
| WO-2021250358-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2021-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230235190-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | TUBB3, TUBA3C, PHB1 | MAPT 318/4885KDM4E 3848/4885RAB9A 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.